IBDEI042 ; ; 09-MAY-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 09, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,5130,1,4,0)
 ;;=4^V13.4
 ;;^UTILITY(U,$J,358.3,5130,1,5,0)
 ;;=5^Personal H/O Arthritis
 ;;^UTILITY(U,$J,358.3,5130,2)
 ;;=^295267
 ;;^UTILITY(U,$J,358.3,5131,0)
 ;;=V12.72^^33^371^51
 ;;^UTILITY(U,$J,358.3,5131,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5131,1,4,0)
 ;;=4^V12.72
 ;;^UTILITY(U,$J,358.3,5131,1,5,0)
 ;;=5^Personal H/O Colon Polyps
 ;;^UTILITY(U,$J,358.3,5131,2)
 ;;=^303401
 ;;^UTILITY(U,$J,358.3,5132,0)
 ;;=V12.59^^33^371^52
 ;;^UTILITY(U,$J,358.3,5132,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5132,1,4,0)
 ;;=4^V12.59
 ;;^UTILITY(U,$J,358.3,5132,1,5,0)
 ;;=5^Personal H/O Congestive Heart Failure
 ;;^UTILITY(U,$J,358.3,5132,2)
 ;;=^303399
 ;;^UTILITY(U,$J,358.3,5133,0)
 ;;=V45.81^^33^371^53
 ;;^UTILITY(U,$J,358.3,5133,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5133,1,4,0)
 ;;=4^V45.81
 ;;^UTILITY(U,$J,358.3,5133,1,5,0)
 ;;=5^Personal H/O Coronary Bypass
 ;;^UTILITY(U,$J,358.3,5133,2)
 ;;=^97129
 ;;^UTILITY(U,$J,358.3,5134,0)
 ;;=V15.84^^33^371^54
 ;;^UTILITY(U,$J,358.3,5134,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5134,1,4,0)
 ;;=4^V15.84
 ;;^UTILITY(U,$J,358.3,5134,1,5,0)
 ;;=5^Personal H/O Exposure To Asbestos
 ;;^UTILITY(U,$J,358.3,5134,2)
 ;;=^303406
 ;;^UTILITY(U,$J,358.3,5135,0)
 ;;=V15.85^^33^371^60
 ;;^UTILITY(U,$J,358.3,5135,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5135,1,4,0)
 ;;=4^V15.85
 ;;^UTILITY(U,$J,358.3,5135,1,5,0)
 ;;=5^Personal H/O Potentially Hazardous Body Fluids
 ;;^UTILITY(U,$J,358.3,5135,2)
 ;;=^303407
 ;;^UTILITY(U,$J,358.3,5136,0)
 ;;=V10.72^^33^371^56
 ;;^UTILITY(U,$J,358.3,5136,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5136,1,4,0)
 ;;=4^V10.72
 ;;^UTILITY(U,$J,358.3,5136,1,5,0)
 ;;=5^Personal H/O Hodgkin's Disease
 ;;^UTILITY(U,$J,358.3,5136,2)
 ;;=^295237
 ;;^UTILITY(U,$J,358.3,5137,0)
 ;;=V15.3^^33^371^57
 ;;^UTILITY(U,$J,358.3,5137,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5137,1,4,0)
 ;;=4^V15.3
 ;;^UTILITY(U,$J,358.3,5137,1,5,0)
 ;;=5^Personal H/O Irradiation
 ;;^UTILITY(U,$J,358.3,5137,2)
 ;;=^295285
 ;;^UTILITY(U,$J,358.3,5138,0)
 ;;=V10.61^^33^371^32
 ;;^UTILITY(U,$J,358.3,5138,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5138,1,4,0)
 ;;=4^V10.61
 ;;^UTILITY(U,$J,358.3,5138,1,5,0)
 ;;=5^Hx Of Lymphoid Leukemia
 ;;^UTILITY(U,$J,358.3,5138,2)
 ;;=Hx of Lymphoid Leukemia^295232
 ;;^UTILITY(U,$J,358.3,5139,0)
 ;;=V12.03^^33^371^33
 ;;^UTILITY(U,$J,358.3,5139,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5139,1,4,0)
 ;;=4^V12.03
 ;;^UTILITY(U,$J,358.3,5139,1,5,0)
 ;;=5^Hx Of Malaria
 ;;^UTILITY(U,$J,358.3,5139,2)
 ;;=Hx of Malaria^303395
 ;;^UTILITY(U,$J,358.3,5140,0)
 ;;=V10.82^^33^371^34
 ;;^UTILITY(U,$J,358.3,5140,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5140,1,4,0)
 ;;=4^V10.82
 ;;^UTILITY(U,$J,358.3,5140,1,5,0)
 ;;=5^Hx Of Malignant Melanoma
 ;;^UTILITY(U,$J,358.3,5140,2)
 ;;=Hx of Malignant Melanoma^295240
 ;;^UTILITY(U,$J,358.3,5141,0)
 ;;=V10.62^^33^371^36
 ;;^UTILITY(U,$J,358.3,5141,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5141,1,4,0)
 ;;=4^V10.62
 ;;^UTILITY(U,$J,358.3,5141,1,5,0)
 ;;=5^Hx Of Myeloid Leukemia
 ;;^UTILITY(U,$J,358.3,5141,2)
 ;;=Hx of Myeloid Leukemia^295233
 ;;^UTILITY(U,$J,358.3,5142,0)
 ;;=V10.63^^33^371^35
 ;;^UTILITY(U,$J,358.3,5142,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5142,1,4,0)
 ;;=4^V10.63
 ;;^UTILITY(U,$J,358.3,5142,1,5,0)
 ;;=5^Hx Of Monocytic Leukemia
 ;;^UTILITY(U,$J,358.3,5142,2)
 ;;=Hx of Monocytic Leukemia^295234
 ;;^UTILITY(U,$J,358.3,5143,0)
 ;;=V11.2^^33^371^30
 ;;^UTILITY(U,$J,358.3,5143,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5143,1,4,0)
 ;;=4^V11.2
 ;;^UTILITY(U,$J,358.3,5143,1,5,0)
 ;;=5^Hx Of Dysthymia
 ;;^UTILITY(U,$J,358.3,5143,2)
 ;;=Hx of Dysthymia^295251
 ;;^UTILITY(U,$J,358.3,5144,0)
 ;;=V15.81^^33^371^46
 ;;^UTILITY(U,$J,358.3,5144,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5144,1,4,0)
 ;;=4^V15.81
 ;;^UTILITY(U,$J,358.3,5144,1,5,0)
 ;;=5^Noncompliance With Medical Treatment
 ;;^UTILITY(U,$J,358.3,5144,2)
 ;;=^295290
 ;;^UTILITY(U,$J,358.3,5145,0)
 ;;=V10.43^^33^371^37
 ;;^UTILITY(U,$J,358.3,5145,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5145,1,4,0)
 ;;=4^V10.43
 ;;^UTILITY(U,$J,358.3,5145,1,5,0)
 ;;=5^Hx Of Ovarian Ca
 ;;^UTILITY(U,$J,358.3,5145,2)
 ;;=Hx of Ovarian CA^295221
 ;;^UTILITY(U,$J,358.3,5146,0)
 ;;=V12.71^^33^371^38
 ;;^UTILITY(U,$J,358.3,5146,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5146,1,4,0)
 ;;=4^V12.71
 ;;^UTILITY(U,$J,358.3,5146,1,5,0)
 ;;=5^Hx Of Peptic Ulcer Disease
 ;;^UTILITY(U,$J,358.3,5146,2)
 ;;=^303400
 ;;^UTILITY(U,$J,358.3,5147,0)
 ;;=V10.46^^33^371^39
 ;;^UTILITY(U,$J,358.3,5147,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5147,1,4,0)
 ;;=4^V10.46
 ;;^UTILITY(U,$J,358.3,5147,1,5,0)
 ;;=5^Hx Of Prostate Cancer
 ;;^UTILITY(U,$J,358.3,5147,2)
 ;;=Hx of Prostate Cancer^295224
 ;;^UTILITY(U,$J,358.3,5148,0)
 ;;=V11.0^^33^371^40
 ;;^UTILITY(U,$J,358.3,5148,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5148,1,4,0)
 ;;=4^V11.0
 ;;^UTILITY(U,$J,358.3,5148,1,5,0)
 ;;=5^Hx Of Schizophrenia
 ;;^UTILITY(U,$J,358.3,5148,2)
 ;;=Hx of Schizophrenia^295249
 ;;^UTILITY(U,$J,358.3,5149,0)
 ;;=V10.83^^33^371^41
 ;;^UTILITY(U,$J,358.3,5149,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5149,1,4,0)
 ;;=4^V10.83
 ;;^UTILITY(U,$J,358.3,5149,1,5,0)
 ;;=5^Hx Of Skin Cancer (Non-Melanoma)
 ;;^UTILITY(U,$J,358.3,5149,2)
 ;;=^295241
 ;;^UTILITY(U,$J,358.3,5150,0)
 ;;=V15.1^^33^371^42
 ;;^UTILITY(U,$J,358.3,5150,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5150,1,4,0)
 ;;=4^V15.1
 ;;^UTILITY(U,$J,358.3,5150,1,5,0)
 ;;=5^Hx Of Surgery To Heart And Great Vessels
 ;;^UTILITY(U,$J,358.3,5150,2)
 ;;=^295283
 ;;^UTILITY(U,$J,358.3,5151,0)
 ;;=V15.82^^33^371^44
 ;;^UTILITY(U,$J,358.3,5151,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5151,1,4,0)
 ;;=4^V15.82
 ;;^UTILITY(U,$J,358.3,5151,1,5,0)
 ;;=5^Hx Of Tobacco Use (Not Current)
 ;;^UTILITY(U,$J,358.3,5151,2)
 ;;=Hx of Tobacco Use (not current)^303405
 ;;^UTILITY(U,$J,358.3,5152,0)
 ;;=V12.01^^33^371^43
 ;;^UTILITY(U,$J,358.3,5152,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5152,1,4,0)
 ;;=4^V12.01
 ;;^UTILITY(U,$J,358.3,5152,1,5,0)
 ;;=5^Hx Of TB
 ;;^UTILITY(U,$J,358.3,5152,2)
 ;;=Hx of TB^303393
 ;;^UTILITY(U,$J,358.3,5153,0)
 ;;=V13.01^^33^371^31
 ;;^UTILITY(U,$J,358.3,5153,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5153,1,4,0)
 ;;=4^V13.01
 ;;^UTILITY(U,$J,358.3,5153,1,5,0)
 ;;=5^Hx Of Kidney Stones
 ;;^UTILITY(U,$J,358.3,5153,2)
 ;;=Hx of Kidney Stones^303403
 ;;^UTILITY(U,$J,358.3,5154,0)
 ;;=V12.51^^33^371^45
 ;;^UTILITY(U,$J,358.3,5154,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5154,1,4,0)
 ;;=4^V12.51
 ;;^UTILITY(U,$J,358.3,5154,1,5,0)
 ;;=5^Hx Of Venous Thrombosis And Embolism
 ;;^UTILITY(U,$J,358.3,5154,2)
 ;;=^303397
 ;;^UTILITY(U,$J,358.3,5155,0)
 ;;=V17.89^^33^371^3
 ;;^UTILITY(U,$J,358.3,5155,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5155,1,4,0)
 ;;=4^V17.89
 ;;^UTILITY(U,$J,358.3,5155,1,5,0)
 ;;=5^Fam Hx Musculosk Dis
 ;;^UTILITY(U,$J,358.3,5155,2)
 ;;=^332861
 ;;^UTILITY(U,$J,358.3,5156,0)
 ;;=V12.54^^33^371^29
 ;;^UTILITY(U,$J,358.3,5156,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5156,1,4,0)
 ;;=4^V12.54
 ;;^UTILITY(U,$J,358.3,5156,1,5,0)
 ;;=5^HX of TIA
 ;;^UTILITY(U,$J,358.3,5156,2)
 ;;=^335309
 ;;^UTILITY(U,$J,358.3,5157,0)
 ;;=V12.54^^33^371^28
 ;;^UTILITY(U,$J,358.3,5157,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5157,1,4,0)
 ;;=4^V12.54
 ;;^UTILITY(U,$J,358.3,5157,1,5,0)
 ;;=5^HX of Stroke w/o Residuals
 ;;^UTILITY(U,$J,358.3,5157,2)
 ;;=^335309
 ;;^UTILITY(U,$J,358.3,5158,0)
 ;;=V15.88^^33^371^26
 ;;^UTILITY(U,$J,358.3,5158,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5158,1,4,0)
 ;;=4^V15.88
 ;;^UTILITY(U,$J,358.3,5158,1,5,0)
 ;;=5^HX of Falls
 ;;^UTILITY(U,$J,358.3,5158,2)
 ;;=^332859
 ;;^UTILITY(U,$J,358.3,5159,0)
 ;;=V13.59^^33^371^27
 ;;^UTILITY(U,$J,358.3,5159,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5159,1,4,0)
 ;;=4^V13.59
 ;;^UTILITY(U,$J,358.3,5159,1,5,0)
 ;;=5^HX of Musculoskletl Dis NEC
 ;;^UTILITY(U,$J,358.3,5159,2)
 ;;=^295268
 ;;^UTILITY(U,$J,358.3,5160,0)
 ;;=V12.04^^33^371^58
 ;;^UTILITY(U,$J,358.3,5160,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5160,1,4,0)
 ;;=4^V12.04
 ;;^UTILITY(U,$J,358.3,5160,1,5,0)
 ;;=5^Personal H/O MRSA infection
 ;;^UTILITY(U,$J,358.3,5160,2)
 ;;=^336780
 ;;^UTILITY(U,$J,358.3,5161,0)
 ;;=V62.22^^33^371^61
 ;;^UTILITY(U,$J,358.3,5161,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5161,1,4,0)
 ;;=4^V62.22
 ;;^UTILITY(U,$J,358.3,5161,1,5,0)
 ;;=5^Personal H/O Retrn Military Deploy
 ;;^UTILITY(U,$J,358.3,5161,2)
 ;;=^336807
 ;;^UTILITY(U,$J,358.3,5162,0)
 ;;=V13.51^^33^371^59
 ;;^UTILITY(U,$J,358.3,5162,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5162,1,4,0)
 ;;=4^V13.51
 ;;^UTILITY(U,$J,358.3,5162,1,5,0)
 ;;=5^Personal H/O Pathological FX
 ;;^UTILITY(U,$J,358.3,5162,2)
 ;;=^336781
 ;;^UTILITY(U,$J,358.3,5163,0)
 ;;=V15.51^^33^371^63
 ;;^UTILITY(U,$J,358.3,5163,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5163,1,4,0)
 ;;=4^V15.51
 ;;^UTILITY(U,$J,358.3,5163,1,5,0)
 ;;=5^Personal H/O Traumatic FX
 ;;^UTILITY(U,$J,358.3,5163,2)
 ;;=^336786
 ;;^UTILITY(U,$J,358.3,5164,0)
 ;;=V15.52^^33^371^62
 ;;^UTILITY(U,$J,358.3,5164,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5164,1,4,0)
 ;;=4^V15.52
 ;;^UTILITY(U,$J,358.3,5164,1,5,0)
 ;;=5^Personal H/O Traumatic Brain Injury
 ;;^UTILITY(U,$J,358.3,5164,2)
 ;;=^338495
 ;;^UTILITY(U,$J,358.3,5165,0)
 ;;=V70.0^^33^372^2
 ;;^UTILITY(U,$J,358.3,5165,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5165,1,4,0)
 ;;=4^V70.0
 ;;^UTILITY(U,$J,358.3,5165,1,5,0)
 ;;=5^Routine Med Exam
 ;;^UTILITY(U,$J,358.3,5165,2)
 ;;=^295590
 ;;^UTILITY(U,$J,358.3,5166,0)
 ;;=V77.91^^33^372^3
 ;;^UTILITY(U,$J,358.3,5166,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5166,1,4,0)
 ;;=4^V77.91
 ;;^UTILITY(U,$J,358.3,5166,1,5,0)
 ;;=5^Screen For High Cholesterol
 ;;^UTILITY(U,$J,358.3,5166,2)
 ;;=Screen for High Cholesterol^322093
